GlassScriptPhysician profile
Nachum Weingarten
NPI 1881703478
$832.90
in general payments reported to CMS, 2019-2025
11 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $125 · 2023: $16.83 · 2024: $189 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $154.39 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $125.00 | 2024 | Mounjaro |
| Verona Pharma, INC. | $125.00 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $120.77 | 2021 | |
| Neuronetics, INC. | $41.62 | 2024 | Neurostar Tms Therapy System |
| Merck Sharp & Dohme LLC | $41.11 | 2021-2024 | |
| Exact Sciences Corporation | $37.44 | 2025 | Cologuard Collection Kit |
| Lnhc, INC | $26.64 | 2025 | Zelsuvmi |
| Alk-Abello, INC | $19.10 | 2025 | Neffy |
| Sanofi Pasteur INC. | $16.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nachum Weingarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.